ICU Medical (NASDAQ:ICUI) Updates FY 2026 Earnings Guidance

ICU Medical (NASDAQ:ICUI) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 7.750-8.450 for the period, compared to the consensus estimate of 7.410. The company issued revenue guidance of -.

ICU Medical Stock Performance

ICUI stock traded down $1.89 during trading on Thursday, reaching $149.74. The stock had a trading volume of 550,179 shares, compared to its average volume of 262,656. The company has a current ratio of 2.45, a quick ratio of 1.19 and a debt-to-equity ratio of 0.62. ICU Medical has a 52 week low of $107.00 and a 52 week high of $164.35. The firm has a market cap of $3.70 billion, a PE ratio of -483.02 and a beta of 0.79. The stock’s 50 day moving average is $149.17 and its two-hundred day moving average is $135.59.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Thursday, February 19th. The medical instruments supplier reported $1.91 earnings per share for the quarter, beating the consensus estimate of $1.68 by $0.23. ICU Medical had a negative net margin of 0.32% and a positive return on equity of 7.71%. The business had revenue of $535.94 million for the quarter, compared to the consensus estimate of $541.20 million. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. As a group, equities analysts anticipate that ICU Medical will post 4.11 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Wall Street Zen raised ICU Medical from a “hold” rating to a “buy” rating in a research report on Sunday. KeyCorp lifted their price objective on shares of ICU Medical from $173.00 to $175.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of ICU Medical in a research note on Thursday, January 22nd. Finally, Piper Sandler raised their target price on shares of ICU Medical from $153.00 to $172.00 and gave the stock an “overweight” rating in a report on Friday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $175.67.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Cibc World Markets Corp purchased a new position in shares of ICU Medical during the 4th quarter worth $228,000. CIBC Asset Management Inc purchased a new position in ICU Medical in the fourth quarter valued at $225,000. CIBC Bancorp USA Inc. purchased a new stake in shares of ICU Medical during the third quarter worth approximately $309,000. Mercer Global Advisors Inc. ADV purchased a new position in ICU Medical in the third quarter worth approximately $304,000. Finally, Lido Advisors LLC increased its holdings in ICU Medical by 7.9% in the third quarter. Lido Advisors LLC now owns 2,373 shares of the medical instruments supplier’s stock valued at $285,000 after buying an additional 174 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.